Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 18.05.2026 1 Arch Virol 4 BMJ 1 Infect Immun 4 Lancet 1 Pediatr Infect Dis J 1 PLoS Med 2 PLoS One 1 Proc Natl Acad Sci U S A 18 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. IQBAL H, Ahmad F, Ahmad S, Ahmad I, et al
   Phylogenetic and genome-wide analysis of codon usage reveals geographic and host-specific adaptation in Vaccinia virus.
   Arch Virol. 2026;171:178.
   PubMed         Abstract available
   
   

   
   BMJ

2. KASSTAN-DABUSH B, Chantler T, Bedford H
   NHS vaccination strategy is set up to fail without a coherent public health agenda.
   BMJ. 2026;393:s857.
   PubMed        
   
   
3. IACOBUCCI G
   Malaria vaccine reduces child deaths by 13% in Africa, WHO study reports.
   BMJ. 2026;393:s900.
   PubMed        
   
   
4. FIELDING S
   FDA blocks publication of studies showing covid and shingles vaccines to be safe.
   BMJ. 2026;393:s896.
   PubMed        
   
   
5. IACOBUCCI G
   Moderna's mRNA flu vaccine outperforms standard shot, study finds.
   BMJ. 2026;393:s895.
   PubMed        
   
   

   
   Infect Immun

6. BHATTACHARYYA A, Mantis NJ
   OspA antibodies inhibit the in vitro transmigration of Borrelia burgdorferi.
   Infect Immun. 2026;94:e0012826.
   PubMed         Abstract available
   
   

   
   Lancet

7. GAYTHORPE KAM, Li X, Shankar M, Hartner AM, et al
   Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study.
   Lancet. 2026;407:1941-1952.
   PubMed         Abstract available
   
   
8. OSEI I, Wutor BM
   Vaccine impact in Gavi-supported countries: balancing evidence with policy needs.
   Lancet. 2026;407:1895-1897.
   PubMed        
   
   
9. MCCLOSKEY B, Petersen E, Azhar EI, Zumla A, et al
   Meningococcal B resurgence in the UK: implications for updating global vaccine strategies.
   Lancet. 2026 May 8:S0140-6736(26)00863-9. doi: 10.1016/S0140-6736(26)00863.
   PubMed        
   
   
10. MWAPASA V, Asante KP, Milligan P, Akech S, et al
    Impact of introducing RTS,S/AS01(E) malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme.
    Lancet. 2026;407:1796-1808.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

11. MARIN M, Raparti L, Leung J, Oliver SE, et al
    Safety and Immunogenicity of Varicella Vaccination in Children and Adolescents Living With HIV: A Systematic Review.
    Pediatr Infect Dis J. 2026 May 11. doi: 10.1097/INF.0000000000005264.
    PubMed         Abstract available
    
    

    
    PLoS Med

12. HYSA A, Opi DH, Waterhouse J, Chishimba S, et al
    Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.
    PLoS Med. 2026;23:e1004877.
    PubMed         Abstract available
    
    

    
    PLoS One

13. KUSEMERERWA S, Kansiime S, Mutonyi G, Kakande A, et al
    Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018-2022 HIV vaccine preparedness cohort in Masaka, Uganda.
    PLoS One. 2026;21:e0348769.
    PubMed         Abstract available
    
    
14. LIU Y, Lu E, Ellingson KD, Hollister J, et al
    Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naive individuals associated with Omicron breakthrough infections.
    PLoS One. 2026;21:e0347602.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

15. GAYTAN MO, Dookie RS, Chakraborty S, Narayana Moorthy A, et al
    Identification of immunostimulatory antigens in Group A Streptococcus-derived vesicles.
    Proc Natl Acad Sci U S A. 2026;123:e2537351123.
    PubMed         Abstract available
    
    

    
    Vaccine

16. FONTENOT HB, Liebermann EJ, Thompson EL, Coad S, et al
    Factors associated with intention to obtain HPV vaccination at ages 9-10 among parents with varied prior vaccine decision making experiences and choices.
    Vaccine. 2026;85:128698.
    PubMed         Abstract available
    
    
17. OPALEYE OO, Esan DT
    Mobile health strategies to improve HPV vaccination uptake among parents of adolescent girls: a scoping review.
    Vaccine. 2026;85:128701.
    PubMed         Abstract available
    
    
18. ANABE D, Ilonen J, Barkoff AM, Terasjarvi JT, et al
    Association of HLA class II haplotypes with antibody concentrations after diphtheria-tetanus acellular pertussis booster vaccination in four age groups of Finnish participants.
    Vaccine. 2026;85:128697.
    PubMed         Abstract available
    
    
19. LADOMENOU F, Gkorla E, Matalliotakis M, Moulias E, et al
    Pregnant women's knowledge, perceptions, and intention to receive a future group B Streptococcus (GBS) vaccine: a cross-sectional study.
    Vaccine. 2026;85:128706.
    PubMed         Abstract available
    
    
20. SHEN Y, Shahn Z, Robertson MM, Gebo K, et al
    Effect of a third COVID-19 vaccine dose on the incidence of Long COVID among adults who completed a primary vaccine series: a target trial emulation in a community-based cohort.
    Vaccine. 2026;84:128666.
    PubMed         Abstract available
    
    
21. THEOTONIO DOS SANTOS LF, Gomes AM, Oliveira DA, Mattos AJC, et al
    HPV vaccine and age of sexual debut of adolescents: A nationwide cross-sectional study.
    Vaccine. 2026;84:128677.
    PubMed         Abstract available
    
    
22. LAMBERT D, Luisi N
    Prevalence and correlates of COVID-19 vaccine uptake among sexual and gender minority adolescents in the southern United States.
    Vaccine. 2026;84:128661.
    PubMed         Abstract available
    
    
23. DONESANA M, Marseglia A, Laterza L, Caimmi SME, et al
    Safety of supervised hospital vaccination in children at risk of hypersensitivity: A 9-year study.
    Vaccine. 2026;84:128663.
    PubMed         Abstract available
    
    
24. YU X, Xie S, Luo Y, Zheng J, et al
    A novel subunit vaccine based on glycoprotein H and glycoprotein L fusion against pseudorabies virus infection.
    Vaccine. 2026;84:128681.
    PubMed         Abstract available
    
    
25. ELLINGSON MK, Sudarsanam V, Goddard K, Tomar A, et al
    Impact of standing orders on vaccine uptake: A systematic review.
    Vaccine. 2026;84:128664.
    PubMed         Abstract available
    
    
26. POURHASHEM Z, Siasi S, Nourani L, Yousefi H, et al
    Multi-antigen transmission-blocking malaria vaccine elicits Th1-biased antibody responses and SMFA-confirmed oocyst reduction in Anopheles stephensi.
    Vaccine. 2026;84:128683.
    PubMed         Abstract available
    
    
27. MISHRA S, Kumar V, Kaur G, Baby BA, et al
    Comparative immunogenicity of monomeric and tetrameric Nipah virus G glycoprotein-based vaccine candidates demonstrate robust antibody responses in both forms.
    Vaccine. 2026;84:128682.
    PubMed         Abstract available
    
    
28. LI R, Liukang C, Yang H, Zhang X, et al
    Rational design and sequence optimization of an mRNA-LNP vaccine elicits protective immunity against infectious bronchitis virus in chickens.
    Vaccine. 2026;84:128685.
    PubMed         Abstract available
    
    
29. HALFMANN PJ, Duffy A, Wang T, Kawaoka Y, et al
    Evaluating the immunogenicity of clade 2 and clade 3 sarbecovirus spike protein nanoparticle vaccines in Syrian hamsters.
    Vaccine. 2026;84:128653.
    PubMed         Abstract available
    
    
30. CORTES-AZUERO O, Vegvari C, Sutcliffe E, Roney E, et al
    Modeling optimal deployment strategies for Nipah vaccines and monoclonal antibodies.
    Vaccine. 2026;84:128688.
    PubMed         Abstract available
    
    
31. SREEKANTH S, Lahon A
    Strategies to enhance DNA vaccine efficacy against emerging arboviruses: lessons from ZIKA and Chikungunya viruses.
    Vaccine. 2026;85:128680.
    PubMed         Abstract available
    
    
32. MARCATO AJ, Campbell PT, Spirkoska V, Ainslie KEC, et al
    Apples and oranges: Better harmonisation of vaccine trials is needed to inform inclusion in immunisation programs.
    Vaccine. 2026;85:128693.
    PubMed        
    
    
33. DAGNEW AF, Noble R, Cinar A, Burhan E, et al
    Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01(E-4) tuberculosis vaccine.
    Vaccine. 2026;85:128690.
    PubMed         Abstract available
    
    

    
    Virology

34. ZHANG Y, Liu L, Chen T, Li M, et al
    CD25(+) cell depletion enhances protective immunity of PR8 inactivated influenza vaccine in aged mice.
    Virology. 2026;621:110938.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum